Age-Stratified Prevalence and Predictors of Neoplasia Among U.S. Adults Undergoing Screening Colonoscopy in a National Endoscopy Registry
- PMID: 35643172
- PMCID: PMC9398947
- DOI: 10.1053/j.gastro.2022.05.036
Age-Stratified Prevalence and Predictors of Neoplasia Among U.S. Adults Undergoing Screening Colonoscopy in a National Endoscopy Registry
Abstract
Background & aims: Several U.S. organizations now recommend starting average-risk colorectal cancer screening at age 45 years, but the prevalence of colonic neoplasia in individuals younger than 50 years has not been well characterized. We used a national endoscopic registry to calculate age-stratified prevalence and predictors of colorectal neoplasia.
Methods: Outpatient screening colonoscopies performed during 2010-2020 in the GI Quality Improvement Consortium registry were analyzed. We measured the prevalence of advanced neoplasia and adenomas by age, sex, and race/ethnicity, as well as the prevalence ratio of neoplasia compared with the reference group of 50- to 54-year-olds. Multivariable logistic regression models were used to identify predictors of neoplasia.
Results: We identified 3,928,727 screening colonoscopies, of which 129,736 (3.3%) were performed on average-risk individuals younger than 50 years. The prevalence of advanced neoplasia was 6.2% for 50- to 54-year-olds and 5.0% (prevalence ratio, 0.81; 95% confidence interval, 0.78-0.83) for average-risk 45- to 49-year-olds. Men had higher prevalence of neoplasia than women for all age groups. White individuals had higher prevalence of advanced neoplasia than persons of other racial/ethnic groups in most age groups, which was partially driven by serrated lesions. On multivariable regression, White individuals had higher odds of advanced neoplasia than Black, Hispanic, and Asian individuals in both younger and older age groups.
Conclusions: In a large U.S. endoscopy registry, the prevalence of advanced neoplasia in 45- to 49-year-olds was substantial and supports beginning screening at age 45 years. White individuals had higher risk of advanced neoplasia than Black, Hispanic, and Asian individuals across the age spectrum. These findings may inform adenoma detection benchmarks and risk-based screening strategies.
Keywords: Advanced Neoplasia; Early-Onset Colorectal Cancer; GIQuIC.
Published by Elsevier Inc.
Figures

Similar articles
-
Prevalence of serrated polyps and association with synchronous advanced neoplasia in screening colonoscopy.Endoscopy. 2014 Mar;46(3):219-24. doi: 10.1055/s-0033-1358800. Epub 2013 Nov 19. Endoscopy. 2014. PMID: 24254386
-
Prevalence and Predictors of Young-Onset Colorectal Neoplasia: Insights From a Nationally Representative Colonoscopy Registry.Gastroenterology. 2022 Apr;162(4):1136-1146.e5. doi: 10.1053/j.gastro.2021.12.285. Epub 2022 Jan 7. Gastroenterology. 2022. PMID: 35007513
-
Risk of Advanced Neoplasia Using the National Cancer Institute's Colorectal Cancer Risk Assessment Tool.J Natl Cancer Inst. 2016 Aug 31;109(1):djw181. doi: 10.1093/jnci/djw181. Print 2017 Jan. J Natl Cancer Inst. 2016. PMID: 27582444 Free PMC article.
-
Adenomas and Sessile Serrated Lesions in 45- to 49-Year-Old Individuals Undergoing Colonoscopy: A Systematic Review and Meta-Analysis.Am J Gastroenterol. 2024 Aug 1;119(8):1600-1606. doi: 10.14309/ajg.0000000000002735. Epub 2024 Feb 29. Am J Gastroenterol. 2024. PMID: 38421004
-
Systematic Review of Prevalence, Risk Factors, and Risk for Metachronous Advanced Neoplasia in Patients With Young-Onset Colorectal Adenoma.Clin Gastroenterol Hepatol. 2021 Apr;19(4):680-689.e12. doi: 10.1016/j.cgh.2020.04.092. Epub 2020 May 16. Clin Gastroenterol Hepatol. 2021. PMID: 32428708 Free PMC article.
Cited by
-
A Score to Predict Advanced Colorectal Neoplasia in Adults Younger than Age 45.Dig Dis Sci. 2025 Apr;70(4):1511-1520. doi: 10.1007/s10620-025-08861-y. Epub 2025 Feb 13. Dig Dis Sci. 2025. PMID: 39946063 Free PMC article.
-
Canadian considerations on updating the age of initiation for colorectal cancer screening in individuals at average risk.Can J Surg. 2025 Aug 8;68(4):E313-E324. doi: 10.1503/cjs.000825. Print 2025 Jul-Aug. Can J Surg. 2025. PMID: 40780872 Free PMC article. Review.
-
Projected Impact and Cost-Effectiveness of Novel Molecular Blood-Based or Stool-Based Screening Tests for Colorectal Cancer.Ann Intern Med. 2024 Dec;177(12):1610-1620. doi: 10.7326/ANNALS-24-00910. Epub 2024 Oct 29. Ann Intern Med. 2024. PMID: 39467291 Free PMC article.
-
Key quality indicators in colonoscopy.Gastroenterol Rep (Oxf). 2023 Mar 10;11:goad009. doi: 10.1093/gastro/goad009. eCollection 2023. Gastroenterol Rep (Oxf). 2023. PMID: 36911141 Free PMC article. Review.
-
Synchronous Neoplasia Rates at Colonoscopic Diagnosis of Early-Onset vs Average-Onset Colorectal Cancer.JAMA Netw Open. 2023 Jul 3;6(7):e2324038. doi: 10.1001/jamanetworkopen.2023.24038. JAMA Netw Open. 2023. PMID: 37462969 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424. - PubMed
-
- Santucci C, Boffetta P, Levi F, et al. Colorectal Cancer Mortality in Young Adults Is Rising in the United States, Canada, United Kingdom, and Australia but Not in Europe and Asia. Gastroenterology 2021. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical